Bristol Myers Squibb (BMY) Operating Expenses (2009 - 2026)
Bristol Myers Squibb (BMY) reported Operating Expenses of $8.2 billion for Q1 2026, little changed year-over-year from $8.2 billion in Q1 2025, and down 25.22% on a QoQ basis from $11.0 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Operating Expenses data on file, last reported at $8.2 billion in Q1 2026.
- Quarterly Operating Expenses changed 0.24% year-over-year to $8.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 billion (down 6.36% YoY) and the FY2025 annual result came in at $38.9 billion, down 31.43% from the prior year.
- Operating Expenses eased to $8.2 billion in Q1 2026 per BMY's latest filing, from $11.0 billion in the prior quarter.
- Across five years, Operating Expenses topped out at $23.4 billion in Q1 2024 and bottomed at $8.2 billion in Q1 2025.
- The 5-year median for Operating Expenses is $9.8 billion (2023), against an average of $10.5 billion.
- The widest annual swing landed in 2024, when Operating Expenses jumped 172.92%; it then tumbled 64.8% in 2025.
- Tracing BMY's Operating Expenses over 5 years: stood at $9.5 billion in 2022, then rose by 2.68% to $9.8 billion in 2023, then advanced by 24.12% to $12.2 billion in 2024, then slipped by 9.33% to $11.0 billion in 2025, then slipped by 25.22% to $8.2 billion in 2026.
- Per Business Quant, the three latest BMY Operating Expenses figures stand at $8.2 billion (Q1 2026), $11.0 billion (Q4 2025), and $9.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 6.72 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 9.59 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 11.01 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 19.82 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 5.95 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 4.37 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 5.50 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 8.25 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.25 Bn |
| Dec 31, 2025 | 11.03 Bn |
| Sep 30, 2025 | 9.11 Bn |
| Jun 30, 2025 | 10.50 Bn |
| Mar 31, 2025 | 8.23 Bn |
| Dec 31, 2024 | 12.17 Bn |
| Sep 30, 2024 | 10.22 Bn |
| Jun 30, 2024 | 10.92 Bn |
| Mar 31, 2024 | 23.38 Bn |
| Dec 31, 2023 | 9.80 Bn |
| Sep 30, 2023 | 8.83 Bn |
| Jun 30, 2023 | 9.37 Bn |
| Mar 31, 2023 | 8.57 Bn |
| Dec 31, 2022 | 9.55 Bn |
| Sep 30, 2022 | 9.01 Bn |
| Jun 30, 2022 | 9.93 Bn |
| Mar 31, 2022 | 9.96 Bn |
| Dec 31, 2021 | 10.13 Bn |
| Sep 30, 2021 | 9.47 Bn |
| Jun 30, 2021 | 10.15 Bn |
| Mar 31, 2021 | 8.54 Bn |
| Dec 31, 2020 | 21.52 Bn |
| Sep 30, 2020 | 8.28 Bn |
| Jun 30, 2020 | 8.50 Bn |
| Mar 31, 2020 | 11.09 Bn |
| Dec 31, 2019 | 8.07 Bn |
| Sep 30, 2019 | 4.66 Bn |
| Jun 30, 2019 | 4.50 Bn |
| Mar 31, 2019 | 3.94 Bn |
| Dec 31, 2018 | 4.47 Bn |
| Sep 30, 2018 | 3.52 Bn |
| Jun 30, 2018 | 5.19 Bn |
| Mar 31, 2018 | 3.41 Bn |
| Dec 31, 2017 | 4.75 Bn |
| Sep 30, 2017 | 4.07 Bn |
| Jun 30, 2017 | 3.85 Bn |
| Mar 31, 2017 | 2.97 Bn |
| Dec 31, 2016 | 4.16 Bn |
| Sep 30, 2016 | 3.36 Bn |
| Jun 30, 2016 | 3.26 Bn |
| Mar 31, 2016 | 2.74 Bn |
| Dec 31, 2015 | 4.70 Bn |
| Sep 30, 2015 | 3.08 Bn |
| Jun 30, 2015 | 4.11 Bn |
| Mar 31, 2015 | 2.59 Bn |
| Dec 31, 2014 | 4.32 Bn |
| Sep 30, 2014 | 2.91 Bn |
| Jun 30, 2014 | 3.44 Bn |
| Mar 31, 2014 | 2.83 Bn |
| Dec 31, 2013 | 3.57 Bn |
| Sep 30, 2013 | 3.25 Bn |
| Jun 30, 2013 | 3.52 Bn |
| Mar 31, 2013 | 3.16 Bn |
| Dec 31, 2012 | 3.68 Bn |
| Sep 30, 2012 | 5.00 Bn |
| Jun 30, 2012 | 3.38 Bn |
| Mar 31, 2012 | 3.22 Bn |
| Dec 31, 2011 | 3.86 Bn |
| Sep 30, 2011 | 3.52 Bn |
| Jun 30, 2011 | 3.64 Bn |
| Mar 31, 2011 | 3.24 Bn |
| Dec 31, 2010 | 3.70 Bn |
| Sep 30, 2010 | 3.18 Bn |
| Jun 30, 2010 | 3.18 Bn |
| Mar 31, 2010 | 3.36 Bn |
| Dec 31, 2009 | 3.71 Bn |
| Sep 30, 2009 | 3.22 Bn |
| Jun 30, 2009 | 3.14 Bn |
| Mar 31, 2009 | 3.13 Bn |